Target intelligence / Profile preview

SLC30A4 antisense RNA 1 (SLC30A4-AS1)

Target
SLC30A4-AS1
Molecular classification
Other (long non-coding RNA)
01

Overview

SLC30A4 antisense RNA 1 (SLC30A4-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 15 in humans[2][5][6]. It is transcribed antisense to the SLC30A4 (ZNT4) zinc transporter gene. There is no evidence this gene encodes a protein or functions as a typical therapeutic target such as a receptor, enzyme, transporter, or signaling molecule. Experimental evidence for its biological function is limited; one study referenced in gene reports suggests that antisense-mediated knock-down of a related lncRNA (hLinfRNA1) can suppress LPS-induced expression of cytokines and pro-inflammatory genes such as IL6, IL1β, and TNFα[7]. No established role in disease, drug interactions, or mechanisms of action have been described. Key notes: - The abbreviation ENSG00000293154 does not correspond to SLC30A4-AS1 in Ensembl or major databases; the current accepted Ensembl identifier for SLC30A4-AS1 is ENSG00000259354[5]. This points to an error or outdated identifier in the original query; thus, is_incorrect: true. - SLC30A4-AS1 is not a canonical drug target (i.e., not a receptor, enzyme, transporter, etc.) and there is minimal evidence for direct involvement in diseases or as a biomarker or druggable target.

Other names
hLinfRNA4
02

Biological functions

Unknownpossibly regulation of gene expressionantisense-mediated knockdown reportedly suppresses expression of cytokines and pro-inflammatory genes such as IL6, IL1β, and TNFα[7]
03

Disease associations

Unknown

Beyond the preview

Go deeper on SLC30A4 antisense RNA 1 (SLC30A4-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC30A4 antisense RNA 1 (SLC30A4-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call